Daniel Ricklin

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 14

Top Venues

ChemMedChem

Immunological reviews

Nature immunology

Blood

Universität Basel

Universität Basel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität Basel

Switzerland

Associate Professor :: Pharmaceutical Sciences

University of Pennsylvania Perelman School of Medicine

United States

Research Associate Professor :: Pathology and Laboratory Medicine

University of Pennsylvania Perelman School of Medicine

United States

Research Assistant Professor :: Pathology and Laboratory Medicine

University of Pennsylvania Perelman School of Medicine

United States

Postdoctoral Researcher :: Pathology and Laboatory Medicine

Universität Basel

Switzerland

Postdoctoral Researcher :: Pharmaceutical Sciences

Education History

Universität Basel

Switzerland

PHD :: Pharmaceutical Sciences

ETH (Swiss Federal Institute of Technology)

Switzerland

MSC :: Pharmaceutical Sciences

Publications

Daniel Ricklin
Complement-targeted therapeutics: Are we there yet, or just getting started? European journal of immunology (2024)
Christina Lamers, Xiaoguang Xue, Martin Smieško, Henri van Son, Bea Wagner, Nadja Berger, Georgia Sfyroera, Piet Gros, John D Lambris, Daniel Ricklin
Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors. Nature communications 13 (1) (2022)
Benedetta Girardi, Martina Manna, Sjors Van Klaveren, Tihomir Tomašič, Žiga Jakopin, Hakon Leffler, Ulf J Nilsson, Daniel Ricklin, Janez Mravljak, Oliver Schwardt, Marko Anderluh
Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside. ChemMedChem (2021)
Seline A Zwarthoff, Kevin Widmer, Annemarie Kuipers, Juergen Strasser, Maartje Ruyken, Piet C Aerts, Carla J C de Haas, Deniz Ugurlar, Maurits A den Boer, Gestur Vidarsson, Jos A G van Strijp, Piet Gros, Paul W H I Parren, Kok P M van Kessel, Johannes Preiner, Frank J Beurskens, Janine Schuurman, Daniel Ricklin, Suzan H M Rooijakkers
C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases. Proceedings of the National Academy of Sciences of the United States of America 118 (26) (2021)
Richard B Pouw, Daniel Ricklin
Tipping the balance: intricate roles of the complement system in disease and therapy. Seminars in immunopathology 43 (6) (2021)
Rachel Hevey, Richard B Pouw, Claire Louise Harris, Daniel Ricklin
Sweet turning bitter: Carbohydrate sensing of complement in host defence and disease. British journal of pharmacology 178 (14) (2020)
Blijke S Kroezen, Gabriele Conti, Benedetta Girardi, Jonathan Cramer, Xiaohua Jiang, Said Rabbani, Jennifer Müller, Maja Kokot, Enrico Luisoni, Daniel Ricklin, Oliver Schwardt, Beat Ernst
A Potent Mimetic of the Siglec-8 Ligand 6'-Sulfo-Sialyl Lewisx. ChemMedChem 15 (18) (2020)
Dimitrios C Mastellos, Anna M Blom, E Sander Connolly, Mohamed R Daha, Brian V Geisbrecht, Berhane Ghebrehiwet, Piet Gros, George Hajishengallis, V Michael Holers, Markus Huber-Lang, Taroh Kinoshita, Tom E Mollnes, Robert A Montgomery, B Paul Morgan, Bo Nilsson, Ruben Pio, Daniel Ricklin, Antonio M Risitano, Ronald P Taylor, Alberto Mantovani, John P A Ioannidis, John D Lambris
'Stealth' corporate innovation: an emerging threat for therapeutic drug development. Nature immunology 20 (11) (2020)
Dimitrios C Mastellos, Daniel Ricklin, John D Lambris
Clinical promise of next-generation complement therapeutics. Nature reviews. Drug discovery 18 (9) (2019)
Daniel Ricklin, John D Lambris
Preformed mediators of defense-Gatekeepers enter the spotlight. Immunological reviews 274 (1) (2018)
Daniel Ricklin, Edimara S Reis, Dimitrios C Mastellos, Piet Gros, John D Lambris
Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense. Immunological reviews 274 (1) (2017)
George Hajishengallis, Edimara S Reis, Dimitrios C Mastellos, Daniel Ricklin, John D Lambris
Novel mechanisms and functions of complement. Nature immunology 18 (12) (2017)
Federico Forneris, Jin Wu, Xiaoguang Xue, Daniel Ricklin, Zhuoer Lin, Georgia Sfyroera, Apostolia Tzekou, Elena Volokhina, Joke Cm Granneman, Richard Hauhart, Paula Bertram, M Kathryn Liszewski, John P Atkinson, John D Lambris, Piet Gros
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode. The EMBO journal 35 (10) (2016)
Markus J Harder, Nadine Kuhn, Hubert Schrezenmeier, Britta Höchsmann, Inge von Zabern, Christof Weinstock, Thomas Simmet, Daniel Ricklin, John D Lambris, Arne Skerra, Markus Anliker, Christoph Q Schmidt
Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation. Blood 129 (8) (2016)
Zhuoer Lin, Christoph Q Schmidt, Sophia Koutsogiannaki, Patrizia Ricci, Antonio M Risitano, John D Lambris, Daniel Ricklin
Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria. Blood 126 (7) (2015)
Markus J Harder, Markus Anliker, Britta Höchsmann, Thomas Simmet, Markus Huber-Lang, Hubert Schrezenmeier, Daniel Ricklin, John D Lambris, Paul N Barlow, Christoph Q Schmidt
Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement Regulation. Journal of immunology (Baltimore, Md. : 1950) 196 (2) (2015)

Daniel Ricklin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Ricklin